The C-Terminal Portion of the Nucleocapsid Protein Demonstrates SARS-CoV Antigenicity

In order to develop clinical diagnostic tools for rapid detection of SARS-CoV (severe acute respiratory syndrome-associated coronavirus) and to identify candidate proteins for vaccine development, the C-terminal portion of the nucleocapsid (NC) gene was amplified using RT-PCR from the SARS-CoV genom...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Genomics, proteomics & bioinformatics proteomics & bioinformatics, 2003-08, Vol.1 (3), p.193-197
Hauptverfasser:	Liu, Guozhen, Hu, Shaohui, Hu, Yongwu, Chen, Peng, Yin, Jianning, Wen, Jie, Wang, Jingqiang, Lin, Liang, Liu, Jinxiu, You, Bo, Yin, Ye, Li, Shuting, Wang, Hao, Ren, Yan, Ji, Jia, Zhao, Xiaoqian, Sun, Yongqiao, Zhang, Xiaowei, Fang, Jianqiu, Wang, Jian, Liu, Siqi, Yu, Jun, Zhu, Heng, Yang, Huanming
Format:	Artikel
Sprache:	eng
Schlagworte:	antigenicity Antigens, Viral - immunology Cloning, Molecular coronavirus Enzyme-Linked Immunosorbent Assay Genetic Vectors Genome, Viral Humans Invited nucleocapsid protein Nucleocapsid Proteins - genetics Nucleocapsid Proteins - immunology Recombinant Fusion Proteins - genetics Recombinant Fusion Proteins - isolation & purification Recombinant Fusion Proteins - metabolism Severe Acute Respiratory Syndrome (SARS) Severe acute respiratory syndrome-related coronavirus - genetics Severe acute respiratory syndrome-related coronavirus - immunology yeast expression system Yeasts - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!